Traders should monitor upcoming commercial launch plans, pricing strategy, and adoption signals from academic and specialty dental centers. Initial revenue impact will likely be minimal, but this could establish a new imaging standard and open a premium segment in dental diagnostics over time.
Price Chart
Executive Summary
Dentsply Sirona and Siemens Healthineers announced FDA clearance for the first dental-dedicated MRI (ddMRI) system, MAGNETOM Free.Max Dental Edition, following a clinical trial confirming its utility in endodontics, periodontics, TMJ, and orthodontics. The technology offers ionizing radiation-free imaging with advanced soft tissue contrast, positioning it as a complementary diagnostic tool for specialized dental applications. While not yet commercially available, the system represents a novel advancement in dental imaging with potential long-term clinical and commercial implications.
Key Facts
- FDA has cleared the MAGNETOM Free.Max Dental Edition, the first dental-dedicated MRI (ddMRI) system.
- Clinical trial validated the system's use in endodontics, periodontics, TMJ, tooth extraction, and orthodontics.
- The ddMRI provides non-ionizing, high-contrast soft tissue imaging with a dental-specific field of view and average workflow time under 20 minutes.
- Target users include hospitals, large clinics, and universities; commercial availability is pending and not guaranteed in all countries.
- Hands-on clinician training is scheduled for April 2026 at the University of Minnesota.
Financial Impact
Long-term revenue opportunity in high-end dental imaging; exact financial impact not disclosed.
Risk Factors
- Commercial availability is not yet confirmed and subject to regulatory and market rollout constraints.
- Adoption may be limited due to high cost, infrastructure requirements, and competition from established modalities like CBCT.
- Revenue contribution is expected to be negligible in the near term; long-term success depends on clinical uptake and reimbursement pathways.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3251807 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 10, 2026 22d ago | Institutional Cluster | $10.50 $9.38 | ▼ −10.71% | ▼ −10.22% | $8.67 (−17.43%) |
Jun 16, 2026 15w ago | Insider Cluster | $10.03 $10.52 | ▲ +4.89% | ▲ +5.93% | $8.67 (−13.56%) |
Jun 15, 2026 15w ago | Insider Cluster | $10.45 $10.20 | ▼ −2.39% | ▼ −0.16% | $8.67 (−17.03%) |
Jun 11, 2026 16w ago | 8-K | $10.14 $10.03 | ▼ −1.08% | ▼ −1.52% | $8.67 (−14.50%) |
May 5, 2026 21w ago | 8-K | $11.14 $11.00 | ▲ +1.26% | ▲ +2.39% | $8.67 (+22.17%) |
May 5, 2026 21w ago | Press Release | $11.14 $11.00 | ▼ −1.26% | ▼ −2.39% | $8.67 (−22.17%) |
Apr 22, 2026 23w ago | Press Release | $11.90 $11.48 | ▼ −3.53% | ▼ −5.01% | $8.67 (−27.14%) |
Mar 9, 2026 29w ago | Press Release | $12.80 $11.73 | ▼ −8.36% | ▼ −7.00% | $8.67 (−32.27%) |
Mar 3, 2026 30w ago | Insider Cluster | $13.30 $12.68 | ▼ −4.66% | ▼ −4.18% | $8.67 (−34.81%) |
Feb 24, 2026 31w ago | 8-K | $12.80 $13.44 | ▲ +5.00% | ▲ +6.10% | $8.67 (−32.27%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access